Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, ...
The 25thAnnual Putnam County Spelling Bee or Putnam, as it’s lovingly referred to by theater connoisseurs on a time crunch, ...
Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...
Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University Hospital (UKHD) using a ...
From fridge art to focal point.
MP0632 nominated as first logic-gated Switch-DARPin T cell engager candidate for the treatment of MSLN/EpCAM expressing solid tumors, with preclinical data indicating favorable therapeutic windowMP071 ...
Hell hath no fury like a well-intentioned self-appointed watchdog challenged, as David Lindsay-Abaire’s new ensemble comedy ...
Abstracts accepted for presentation provide updates on ongoing EVEREST-2 clinical study and describe approaches to boost ...
Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. It has been ...
Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results